Hepatitis C in Primary Care (QLD)
On-demand recorded 14 Jul 2021
The Australian Government has endorsed the World Health Organisation targets of 90% of people living with chronic HCV infection to be diagnosed, with 80% treatment coverage by 2030. Since the introduction of interferon-free direct acting antiviral (DAA) therapy on the Pharmaceutical Benefits Scheme in March 2016, an estimated 70, 260 people have been treated in Australia.
Australia is a world leader in progressing the elimination of HCV as a public health threat by 2030. A key feature of the Australian HCV treatment landscape since the DAA program commenced has been the involvement of non-specialists in prescribing.
Join Dr Jodi Stevenson for this free interactive webinar which provides general practitioners in primary and related care settings with an overview of the hepatitis C management in primary care settings in Qld including case finding, testing, patient assessment and treatment.
- Identify priority populations for HCV screening
- Order and interpret tests appropriately to diagnose chronic HCV infection
- Describe the recommended pre-treatment assessment
- Demonstrate understanding of antiviral therapy for treatment of HCV
- Communicate confidently with patients about HCV
This event attracts 3 CPD points
This event is part of ASHM Series. Events in this series are:
Dr Michael Burke
Michael Burke works in Western Sydney GP. He is committed to improving health equity, treatment and care for people with blood borne viruses including HIV. He works in whole person medicine framework, and enjoys getting to know his patients, reading, writing, and birdwatching.
Dr Jodi Stevenson
General Practitioner, Inala Health Service
Dr Jodi Stevenson is a GP who has worked in Indigenous Health for the last 20 years. She has been working at Inala Indigenous Health in Brisbane since 2014. As liver disease and Hepatitis C is over represented in this community, she has pursued a specialist interest in prescribing in this area.